AIRLINK 198.65 Decreased By ▼ -2.10 (-1.05%)
BOP 10.10 Decreased By ▼ -0.11 (-1.08%)
CNERGY 7.63 Decreased By ▼ -0.08 (-1.04%)
FCCL 39.50 Decreased By ▼ -0.56 (-1.4%)
FFL 16.60 Decreased By ▼ -0.21 (-1.25%)
FLYNG 26.40 Decreased By ▼ -0.25 (-0.94%)
HUBC 132.10 Decreased By ▼ -0.50 (-0.38%)
HUMNL 14.09 Increased By ▲ 0.17 (1.22%)
KEL 4.66 Increased By ▲ 0.01 (0.22%)
KOSM 6.61 Increased By ▲ 0.02 (0.3%)
MLCF 46.10 Decreased By ▼ -0.64 (-1.37%)
OGDC 213.00 Increased By ▲ 0.57 (0.27%)
PACE 6.88 Decreased By ▼ -0.02 (-0.29%)
PAEL 42.85 Increased By ▲ 1.57 (3.8%)
PIAHCLA 17.11 Increased By ▲ 0.11 (0.65%)
PIBTL 8.08 Decreased By ▼ -0.03 (-0.37%)
POWER 9.29 Decreased By ▼ -0.13 (-1.38%)
PPL 181.99 Increased By ▲ 0.53 (0.29%)
PRL 41.20 Decreased By ▼ -0.58 (-1.39%)
PTC 26.22 Increased By ▲ 1.52 (6.15%)
SEARL 110.40 Decreased By ▼ -1.44 (-1.29%)
SILK 1.01 Increased By ▲ 0.01 (1%)
SSGC 42.80 Decreased By ▼ -1.12 (-2.55%)
SYM 19.45 Increased By ▲ 0.47 (2.48%)
TELE 8.90 Increased By ▲ 0.03 (0.34%)
TPLP 12.86 Decreased By ▼ -0.06 (-0.46%)
TRG 66.92 Decreased By ▼ -0.55 (-0.82%)
WAVESAPP 11.45 Increased By ▲ 0.03 (0.26%)
WTL 1.79 No Change ▼ 0.00 (0%)
YOUW 3.96 Decreased By ▼ -0.03 (-0.75%)
BR100 12,214 Increased By 43.4 (0.36%)
BR30 36,602 Increased By 13.3 (0.04%)
KSE100 115,021 Increased By 140.8 (0.12%)
KSE30 36,144 Increased By 19.4 (0.05%)

Pakistan Pharmaceutical Manufacturers' Association (PPMA) Chairman Mansoor Dilawar said that around 40 to 50 medicines are in short supply, and the number would soon cross 100.

Dilawar told Business Recorder that over 40 life-saving drugs are not available after the pharma industry decided not to import raw materials because of GST imposition.

The medicines short in the market include Alp tablets used for anti-depression, Dexamethasone for asthma, cancer, and joint pain, Epitab for epilepsy, Nervin for depression, Epival, Fexet D, Nitronal, Ventoline tablets, and injections.

Moreover, Epival In, Myrin P, Ketasol Inj, Loprin, Silver tab, phenergen Elixir, Tixylix Lincitilus, Chlooriptics Drops, systane drops, Rivotril drops, Dormicum tablets, Winstor, Tritace, Sodamint, Schazobutil, Jardymet, and Brufen are reportedly short in the market.

Drugs: manufacturers demand increase in MRP, abolition of sales tax

Lomotil, Panadol, Tan Primolut B, Progynova, Stilnix, Glucobay, Zentel, Avor, Gravibinan, Syp Gaviscon, Lipofundin, and Sorbid Injection are also not available.

The PPMA chairman said that the industry was suspending production of low-margin items after the Federal Board of Revenue (FBR) imposed taxes that jacked up the industry’s cost of production by Rs60 billion to Rs70 billion.

“Pharma industry cannot pass on the higher cost of production to consumers because there is a cap on drug prices,” he said.

“So, the industry has been forced to suspend production of low-margin medicines, which have become un-viable after an increase in taxes,” Dilawar added.

Dilawar said that the industry is paying 17% refundable GST at the import stage.

"There's a non-refundable 1% tax on raw materials. And then the government has imposed a 1% on the sale of medicines. This will force the industry to pay taxes of Rs60 billion to Rs70 billion annually."

A few days ago, the PPMA chairman said that the pharmaceutical industry is awaiting sales tax refunds of Rs40 billion since January 16, 2022. However, the FBR has denied that there were any refunds stuck with the tax authority.

Comments

Comments are closed.